Regulation of reovirus induced apoptosis
呼肠孤病毒诱导细胞凋亡的调节
基本信息
- 批准号:8535905
- 负责人:
- 金额:$ 40.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-19 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntiviral AgentsApoptosisApoptoticAreaAutoimmunityBiologyBrainC-terminalCalcineurinCalciumCalpainCapsid ProteinsCaspaseCell membraneCell physiologyCellsCellular MembraneCellular StressChelating AgentsClinicalClinical TrialsCultured CellsCytosolDengue VirusDevelopmentDiseaseDisease OutcomeEctopic ExpressionEncephalitisExtravasationFosteringHeartHomeostasisHumanHuman ActivitiesHuman VirusInduction of ApoptosisInfectionInjuryLaboratoriesLeadLiverMalignant NeoplasmsMediatingMembraneModelingMolecularMusMutationMyocarditisNewborn InfantNormal tissue morphologyOncolyticPathogenesisPathogenicityPathologicPathway interactionsPharmaceutical PreparationsPhasePost-Translational Protein ProcessingProcessProteinsPublic HealthRegulationReoviridae InfectionsReovirusResearchRoleSafetySignal PathwaySignaling MoleculeSiteStudy modelsTestingTherapeutic AgentsTimeTissuesTransformed Cell LineUbiquitinationViralViral PathogenesisViral Structural ProteinsVirusVirus DiseasesWest Nile viruscancer therapycell killingcytotoxicityexperienceimprovedin vivoinfluenzavirusmutantneoplastic cellnoveloncolytic vectorresearch studyresponsetherapeutic targettumor
项目摘要
DESCRIPTION (provided by applicant): In this proposal we seek to understand the underlying mechanisms by which reoviruses induce apoptosis in cells and how this process is regulated to optimize viral replication in cultured cells and in vivo. Apoptosis is an evolutionarily conserved mechanism by which cells are removed during development and normal tissue homeostasis is maintained. Under pathologic conditions, suppression of apoptosis can lead to cancer and autoimmunity or conversely induction of apoptosis can lead to tissue injury. Many pathogenic human viruses, e.g., dengue virus, influenza virus, and West Nile virus, cause disease by inducing apoptosis. Some viruses induce apoptosis late in the infectious cycle, which allows the virus to spread within the host. Little is known about how viruses regulate the initiation and timing of apoptosis induction. Mammalian reoviruses are important models for identification of general pathogenic mechanisms by which viruses cause disease. Reoviruses cause pathologic damage (myocarditis and encephalitis) by inducing apoptosis. In addition, these viruses preferentially target transformed cell lines and are showing increasing promise as oncolytic agents because of their safety in humans and activity against a broad range of tumor types (they are currently being tested in several phase II/III clinical trials). Importantly, the primary mechanism of tumor cell killing is by virus-induced apoptosis. Here we will use the reovirus model to dissect the process of virus-induced apoptosis and its regulation by focusing on the viral structural protein, ?1, which functions to permeabilize cell membranes during virus entry and induces apoptosis later in the infectious cycle. Two specific aims are proposed. In the first, mechanisms by which outer-capsid protein ?1 induces apoptosis will be determined. These experiments will test the hypothesis that a C-terminal fragment of ?1 is a viroporin that can directly permeabilize cellular membranes, including the plasma membrane, allowing leakage of molecules into the cytosol that activate cellular stress pathways, inducing apoptosis. In the second, post-translational modifications of ?1 that regulate the induction of apoptosis, cytotoxicity, and pathogenesis will be defined. These experiments will test the hypothesis that proteolytic cleavage and ubiquitination of free ?1 in the cytosol of infected cells regulates virus release, cytotoxicity, and pathogenicity. Collectively, these studies will enhance a basic understanding of virus-induced cell killing and may foster development of improved reovirus vectors for oncolytic applications and lead to new antiviral therapeutics that target apoptotic pathways.
描述(由申请人提供):在该提案中,我们试图了解呼肠孤病毒诱导细胞凋亡的潜在机制,以及如何调节该过程以优化培养细胞和体内的病毒复制。细胞凋亡是一种进化上保守的机制,通过这种机制,细胞在发育过程中被去除,正常组织的稳态得以维持。在病理条件下,细胞凋亡的抑制可导致癌症,自身免疫或相反地诱导细胞凋亡可导致组织损伤。许多致病性人类病毒,例如,登革热病毒、流感病毒和西尼罗河病毒通过诱导细胞凋亡引起疾病。一些病毒在感染周期的后期诱导细胞凋亡,这使得病毒在宿主内传播。关于病毒如何调节细胞凋亡诱导的起始和时机知之甚少。哺乳动物呼肠孤病毒是鉴定病毒引起疾病的一般致病机制的重要模型。呼肠孤病毒通过诱导细胞凋亡引起病理损伤(心肌炎和脑炎)。此外,这些病毒优先靶向转化的细胞系,并且由于其在人体中的安全性和对广泛肿瘤类型的活性而显示出作为溶瘤剂的越来越大的前景(它们目前正在几个II/III期临床试验中进行测试)。重要的是,肿瘤细胞杀伤的主要机制是通过病毒诱导的细胞凋亡。在这里,我们将使用呼肠孤病毒模型解剖的过程中,病毒诱导的细胞凋亡及其调控的病毒结构蛋白,?1,其功能是在病毒进入期间透化细胞膜,并在感染周期后期诱导细胞凋亡。提出了两个具体目标。在第一,机制由哪些外衣壳蛋白?1诱导细胞凋亡。这些实验将检验以下假设:?1是一种病毒孔蛋白,其可以直接透化细胞膜,包括质膜,允许分子渗漏到细胞溶质中,从而激活细胞应激途径,诱导细胞凋亡。在第二,翻译后修饰?1调节细胞凋亡诱导、细胞毒性和发病机制的作用将被定义。这些实验将测试的假设,蛋白水解切割和泛素化的自由?1调节病毒释放、细胞毒性和致病性。总的来说,这些研究将增强对病毒诱导的细胞杀伤的基本理解,并可能促进用于溶瘤应用的改进的呼肠孤病毒载体的开发,并导致靶向凋亡途径的新的抗病毒治疗。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Virus-mediated compartmentalization of the host translational machinery.
- DOI:10.1128/mbio.01463-14
- 发表时间:2014-09-16
- 期刊:
- 影响因子:6.4
- 作者:Desmet EA;Anguish LJ;Parker JS
- 通讯作者:Parker JS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John S Parker其他文献
John S Parker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John S Parker', 18)}}的其他基金
Mechanisms of virus-mediated compartmentalization of the host translational machinery
病毒介导的宿主翻译机制区室化机制
- 批准号:
9174898 - 财政年份:2015
- 资助金额:
$ 40.81万 - 项目类别:
Mechanisms of virus-mediated compartmentalization of the host translational machinery
病毒介导的宿主翻译机制区室化机制
- 批准号:
9010465 - 财政年份:2015
- 资助金额:
$ 40.81万 - 项目类别:
Studies of the global translational response to human virus infection
对人类病毒感染的全球转化反应的研究
- 批准号:
8803766 - 财政年份:2014
- 资助金额:
$ 40.81万 - 项目类别:
Studies of the global translational response to human virus infection
对人类病毒感染的全球转化反应的研究
- 批准号:
8702355 - 财政年份:2014
- 资助金额:
$ 40.81万 - 项目类别:
3-D ULTRASTRUCTURAL STUDIES OF RETROVIRUS FACTORIES
逆转录病毒工厂的 3-D 超微结构研究
- 批准号:
7598370 - 财政年份:2007
- 资助金额:
$ 40.81万 - 项目类别:
3-D ULTRASTRUCTURAL STUDIES OF RETROVIRUS FACTORIES
逆转录病毒工厂的 3-D 超微结构研究
- 批准号:
7357292 - 财政年份:2006
- 资助金额:
$ 40.81万 - 项目类别:
Reovirus Factories: Structure, Function, and Dynamics
呼肠孤病毒工厂:结构、功能和动力学
- 批准号:
7093542 - 财政年份:2005
- 资助金额:
$ 40.81万 - 项目类别:
Reovirus Factories: Structure, Function, and Dynamics
呼肠孤病毒工厂:结构、功能和动力学
- 批准号:
7541767 - 财政年份:2005
- 资助金额:
$ 40.81万 - 项目类别:
Reovirus Factories: Structure, Function, and Dynamics
呼肠孤病毒工厂:结构、功能和动力学
- 批准号:
7333314 - 财政年份:2005
- 资助金额:
$ 40.81万 - 项目类别:
Reovirus Factories: Structure, Function, and Dynamics
呼肠孤病毒工厂:结构、功能和动力学
- 批准号:
6967319 - 财政年份:2005
- 资助金额:
$ 40.81万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 40.81万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 40.81万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 40.81万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 40.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 40.81万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 40.81万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 40.81万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 40.81万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 40.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 40.81万 - 项目类别: